Continues To Put In Work Despite Market Weakness: MetLife, Inc. (MET)

Wall Street analysts will be watching closely when MetLife, Inc. (NYSE:MET) reports its quarterly earnings next, which is scheduled for Wed 1 May (In 80 Days). Looking at the latest analyst forecasts, the current earnings-per-share (EPS) consensus estimate is sitting at $1.29 per share. In the preceding quarter, the company reportedly generated EPS of $1.35 per share of its common stock. Looking at profitability indicators, this organization has an operating margin of 8.80%, a profit margin of 7.80% and a gross margin of .

Speaking of Wall Street analysts, a number of market experts at top investment banks have recently posted their updated ratings on shares of MetLife, Inc. (NYSE:MET). Most recently, on January 16th, 2019, BofA/Merrill Upgrade a Buy rating. Before that, on January 2nd, 2019, Sandler O’Neill Upgrade to Buy. Goldman Downgrade a Neutral rating on June 4th, 2018, Credit Suisse Initiated an Outperform rating on April 25th, 2018, and Atlantic Equities Upgrade a Overweight rating on March 26th, 2018.

At its current price point, combined with the fact that this company has 977.07M shares outstanding, the current market capitalization sits at 41.73B. In the last trading day, 9,352,868 shares of MetLife, Inc. were traded, which compares to its usual volume of about 6.78M shares per day of trading.

If we compare this company’s current price to its recent pricing activity, we can see that the price has changed by -$2.83 in the past five trading days, resulting in a percentage change of -6.21% and a moving average of 44.36. In the past 20 days, its price changed by -$0.66 (which is -1.52%) and the stock’s moving average was 44.75. Looking back a full 50 days, shares of MET changed by -$1.08 (which is -2.47%) and demonstrated a moving average of 42.66.

Staying in the same analytical area, this company’s stock has demonstrated a 9-day Stochastic %K score of 31.78%, a 14-day Stochastic %K score of 35.56% and a 20-day Stochastic %K score of 39.45%. Using a similar metric, MetLife, Inc. (MET) shares showed a Stochastic %D of 43.58% over the past 9 days, a Stochastic %D score of 50.47% over the last 14 days, and a 20-day Stochastic %D of 59.36%. Meanwhile, this stock’s MACD Oscillator was -0.98 over the past 9 days, -1.05 over the past two weeks, and -0.94 in the last 20 days.

As recent trading data suggests, this company’s shares have been hovering close to the $42.71 level. Over the past 12 months, this stock has experienced a high price of $48.92 and a low of $37.76. Top market experts pay heightened attention to a stock as it is getting closer to a notable historic high price or low price.

The Vanguard Group Inc sold more shares of this company during the last fiscal quarter, as we can observe in the latest corresponding filing from MetLife, Inc. (NYSE:MET) with the Securities and Exchange Commission (SEC). This specific major shareholder, at the end of the quarter, held 64,967,556 shares of the company’s stock following the subtraction of -2,140,380 to this investor’s holdings during the three-month period. This share count represents that The Vanguard Group Inc now held 6.58% stake in MetLife, Inc. (MET)’s shares.

Just in the most recent trading day, MetLife, Inc. (NYSE:MET) experienced a high price of $43.685 and low point of $42.04. At the end of the last trading session, this stock was at 42.71 per share, following a loss of -$0.31, or -1.86% during the full day.